Theravectys

Developer of vaccines to treat infectious diseases and cancer caused by HTLV-1 infection

placeParis, Ile De France, France calendar_todayFounded 2005 groups19 employees language theravectys.com

Registered entities

Investor mix

8 investors on record; lead investors include FGP Capital, iXLife Capital.

Investor typeCountShare
Venture capital113%
Bank & private debt113%
Other / undisclosed675%
Coming soon